BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22870217)

  • 21. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.
    Patrawala L; Calhoun T; Schneider-Broussard R; Zhou J; Claypool K; Tang DG
    Cancer Res; 2005 Jul; 65(14):6207-19. PubMed ID: 16024622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line.
    Martins-Neves SR; Lopes ÁO; do Carmo A; Paiva AA; Simões PC; Abrunhosa AJ; Gomes CM
    BMC Cancer; 2012 Apr; 12():139. PubMed ID: 22475227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.
    Wang Z; Tan M; Chen G; Li Z; Lu X
    IUBMB Life; 2017 Nov; 69(11):867-876. PubMed ID: 28960757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
    Alberti L; Losi L; Leyvraz S; Benhattar J
    PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BMP-2 inhibits the tumorigenicity of cancer stem cells in human osteosarcoma OS99-1 cell line.
    Wang L; Park P; Zhang H; La Marca F; Claeson A; Valdivia J; Lin CY
    Cancer Biol Ther; 2011 Mar; 11(5):457-63. PubMed ID: 21178508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HDAC2 depletion promotes osteosarcoma's stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy.
    La Noce M; Paino F; Mele L; Papaccio G; Regad T; Lombardi A; Papaccio F; Desiderio V; Tirino V
    J Exp Clin Cancer Res; 2018 Dec; 37(1):296. PubMed ID: 30509303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo.
    Tirino V; Desiderio V; Paino F; De Rosa A; Papaccio F; Fazioli F; Pirozzi G; Papaccio G
    FASEB J; 2011 Jun; 25(6):2022-30. PubMed ID: 21385990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ABCG1 and Pgp identify drug resistant, self-renewing osteosarcoma cells.
    Roundhill EA; Jabri S; Burchill SA
    Cancer Lett; 2019 Jul; 453():142-157. PubMed ID: 30910588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck.
    Okamoto A; Chikamatsu K; Sakakura K; Hatsushika K; Takahashi G; Masuyama K
    Oral Oncol; 2009 Jul; 45(7):633-9. PubMed ID: 19027347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer stem cells in osteosarcoma.
    Brown HK; Tellez-Gabriel M; Heymann D
    Cancer Lett; 2017 Feb; 386():189-195. PubMed ID: 27894960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. WNT5B drives osteosarcoma stemness, chemoresistance and metastasis.
    Perkins RS; Murray G; Suthon S; Davis L; Perkins NB; Fletcher L; Bozzi A; Schreiber SL; Lin J; Laxton S; Pillai RR; Wright AJ; Miranda-Carboni GA; Krum SA
    Clin Transl Med; 2024 May; 14(5):e1670. PubMed ID: 38689429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.
    Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; Carlisi D; De Blasio A; Tesoriere G; Giordano A; Vento R
    J Cell Physiol; 2016 Aug; 231(8):1832-41. PubMed ID: 26679758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer.
    Jiang Y; He Y; Li H; Li HN; Zhang L; Hu W; Sun YM; Chen FL; Jin XM
    Gastric Cancer; 2012 Oct; 15(4):440-50. PubMed ID: 22395309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness.
    Di Fiore R; Fanale D; Drago-Ferrante R; Chiaradonna F; Giuliano M; De Blasio A; Amodeo V; Corsini LR; Bazan V; Tesoriere G; Vento R; Russo A
    J Cell Physiol; 2013 Jun; 228(6):1189-201. PubMed ID: 23129384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacodynamics of the G-quadruplex-stabilizing telomerase inhibitor 3,11-difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in vitro: activity in human tumor cells correlates with telomere length and can be enhanced, or antagonized, with cytotoxic agents.
    Cookson JC; Dai F; Smith V; Heald RA; Laughton CA; Stevens MF; Burger AM
    Mol Pharmacol; 2005 Dec; 68(6):1551-8. PubMed ID: 16150933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance.
    Adhikari AS; Agarwal N; Wood BM; Porretta C; Ruiz B; Pochampally RR; Iwakuma T
    Cancer Res; 2010 Jun; 70(11):4602-12. PubMed ID: 20460510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection and characterization of CD133+ cancer stem cells in human solid tumours.
    Tirino V; Desiderio V; d'Aquino R; De Francesco F; Pirozzi G; Graziano A; Galderisi U; Cavaliere C; De Rosa A; Papaccio G; Giordano A
    PLoS One; 2008; 3(10):e3469. PubMed ID: 18941626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of nestin, CD133 and ABCG2 in relation to the clinical outcome in pediatric sarcomas.
    Zambo I; Hermanova M; Zapletalova D; Skoda J; Mudry P; Kyr M; Zitterbart K; Sterba J; Veselska R
    Cancer Biomark; 2016 Jun; 17(1):107-16. PubMed ID: 27314299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity.
    Gatti M; Solari A; Pattarozzi A; Campanella C; Thellung S; Maniscalco L; De Maria R; Würth R; Corsaro A; Bajetto A; Ratto A; Ferrari A; Daga A; Barbieri F; Florio T
    Exp Cell Res; 2018 Feb; 363(1):48-64. PubMed ID: 29305964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
    Wang L; Park P; La Marca F; Than KD; Lin CY
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.